Wednesday, December 26, 2018 10:50:55 PM
With approximately 1 billion shares outstanding, you would probably need to see them buy back at least 10% of the shares, which would amount to 100 million shares, to make a difference for shareholders. At the current market price of $6.81 CAD - and they would usually buy back the shares at a premium to entice shareholders to sell, say $8.50 - it would cost ACB $850 million cash to buy these shares back. ACB currently has $500 million in cash and cash equivalents on its balance sheet, but they need that working capital to pay for daily operations, etc. They could borrow the money to buy back shares, but I am not sure if management would deem this wise in their expansion phase.
Great point about the Mexican acquisition - ACB will likely issue new shares to pay for this acquisition (as it has done with most of its acquisitions in the past), which will further dilute its ownership base. So as we saw with all the previous acquisitions in the past, we will likely see a decrease in share price right after the acquisition due to the increase in shares outstanding. This is frustrating for current shareholders.
Another point that I will add is that as ACB continues to rapidly expand, one of the challenges will be to integrate those new operations into existing operations, align supply chains, ensure quality control, etc. This does pose risks as if there are quality issues, it can damage ACB's brand or result in expensive recalls. Being big doesn't necessarily mean being better, and consumers will discover which products from different companies they prefer and will go with those.
ACB will also need to be aware of its all in productions costs for cannabis and continue to drive those down in order to remain profitable as the retail price for the recreation market in Canada could decline as provinces attempt to stamp out the black market.
Recent ACB News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/06/2024 12:34:40 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/06/2024 12:13:20 PM
- Aurora Cannabis Announces Fiscal 2025 Second Quarter Results • PR Newswire (US) • 11/06/2024 12:00:00 PM
- Aurora Cannabis Announces Fiscal 2025 Second Quarter Results • PR Newswire (Canada) • 11/06/2024 12:00:00 PM
- U.S. Index Futures Surge on Trump Victory Prospects; Commodities Slide Amid Dollar Strength • IH Market News • 11/06/2024 11:12:52 AM
- Aurora Introduces Innovative Cannabis Oil Range to Meet Diverse Patient Needs in Australia • PR Newswire (Canada) • 10/16/2024 11:00:00 AM
- Aurora Introduces Innovative Cannabis Oil Range to Meet Diverse Patient Needs in Australia • PR Newswire (US) • 10/16/2024 11:00:00 AM
- Aurora Cannabis Announces Collaboration on Genome BC-Funded Project Addressing Distinct Cannabis Aromas • PR Newswire (US) • 10/02/2024 11:00:00 AM
- Aurora Cannabis Announces Collaboration on Genome BC-Funded Project Addressing Distinct Cannabis Aromas • PR Newswire (Canada) • 10/02/2024 11:00:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 09/20/2024 08:12:04 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/20/2024 11:19:42 AM
- Aurora CEO Miguel Martin takes on additional role as Executive Chairman of Board of Directors • PR Newswire (US) • 09/20/2024 11:00:00 AM
- Aurora CEO Miguel Martin takes on additional role as Executive Chairman of Board of Directors • PR Newswire (Canada) • 09/20/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/17/2024 11:19:40 AM
- Aurora Cannabis Advances Auto-Flowering Research, Unveiling Key Insights for Future Cultivation Excellence • PR Newswire (Canada) • 09/17/2024 11:00:00 AM
- Aurora Cannabis Advances Auto-Flowering Research, Unveiling Key Insights for Future Cultivation Excellence • PR Newswire (US) • 09/17/2024 11:00:00 AM
- Aurora Cannabis and Vectura Fertin Pharma, Inc. announce launch of novel Luo CBD lozenge • PR Newswire (Canada) • 09/09/2024 11:00:00 AM
- Aurora Cannabis and Vectura Fertin Pharma, Inc. announce launch of novel Luo CBD lozenge • PR Newswire (US) • 09/09/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/26/2024 08:06:36 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/12/2024 05:54:03 PM
- Aurora Cannabis Announces Results of 2024 Annual General and Special Meeting • PR Newswire (Canada) • 08/12/2024 11:00:00 AM
- Aurora Cannabis Announces Results of 2024 Annual General and Special Meeting • PR Newswire (US) • 08/12/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/07/2024 11:19:23 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/07/2024 11:15:12 AM
- US Index Futures Rise Amid Earnings Season Optimism, Oil Prices Rebound • IH Market News • 08/07/2024 09:49:12 AM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM